Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2826620rdf:typepubmed:Citationlld:pubmed
pubmed-article:2826620lifeskim:mentionsumls-concept:C0205474lld:lifeskim
pubmed-article:2826620lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:2826620lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:2826620lifeskim:mentionsumls-concept:C0034804lld:lifeskim
pubmed-article:2826620lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:2826620lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:2826620lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:2826620pubmed:issue1lld:pubmed
pubmed-article:2826620pubmed:dateCreated1988-2-25lld:pubmed
pubmed-article:2826620pubmed:abstractTextCorrelation of structural and functional data might lead to better identification of hormone-dependent tumors. Sixty breast cancer specimens, sent to the biochemistry laboratory for estrogen receptor (ER) analysis, were studied here by a combined morpho-functional approach. Histological examination of needle biopsies on frozen tissue blocks showed that 12 cases (10%) were free of tumor cells; these cases mostly proved ER negative. On the other 48 cases, an immunocytochemical reaction was performed on the biopsy sections with a monoclonal antibody directed against p 29, an estrogen receptor related antigen. The staining values for p 29 and the biochemical ER findings were significantly correlated. A combined histological, immunocytochemical study seems to offer advantages in the selection of patients for hormonal therapy.lld:pubmed
pubmed-article:2826620pubmed:languageenglld:pubmed
pubmed-article:2826620pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2826620pubmed:citationSubsetIMlld:pubmed
pubmed-article:2826620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2826620pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2826620pubmed:statusMEDLINElld:pubmed
pubmed-article:2826620pubmed:issn0393-6155lld:pubmed
pubmed-article:2826620pubmed:authorpubmed-author:Di CarloFFlld:pubmed
pubmed-article:2826620pubmed:authorpubmed-author:BussolatiGGlld:pubmed
pubmed-article:2826620pubmed:authorpubmed-author:GugliottaPPlld:pubmed
pubmed-article:2826620pubmed:authorpubmed-author:PietribiasiFFlld:pubmed
pubmed-article:2826620pubmed:authorpubmed-author:RaccaSSlld:pubmed
pubmed-article:2826620pubmed:issnTypePrintlld:pubmed
pubmed-article:2826620pubmed:volume1lld:pubmed
pubmed-article:2826620pubmed:ownerNLMlld:pubmed
pubmed-article:2826620pubmed:authorsCompleteYlld:pubmed
pubmed-article:2826620pubmed:pagination9-14lld:pubmed
pubmed-article:2826620pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:meshHeadingpubmed-meshheading:2826620-...lld:pubmed
pubmed-article:2826620pubmed:articleTitleA combined histological, immunocytochemical and biochemical approach in the evaluation of estrogen receptors in breast carcinomas.lld:pubmed
pubmed-article:2826620pubmed:affiliationDepartment of Biomedical Sciences and Human Oncology, University of Turin.lld:pubmed
pubmed-article:2826620pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2826620pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2826620pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed